Skinvisible Pharmaceuticals, Inc. Announces Forming of Kintari

Written by Skinvisible

Skinvisible Pharmaceuticals, Inc. announced the forming of Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skin care products powered by the company's patented Invisicare® technology. As part of the company's strategic focus on revenue generation and creating shareholder value, Kintari will be a direct sales company that will launch products initially in the United States and Canada. The Kintari product portfolio consists of "Youth Renewed" (YR) anti-aging products to help fight the signs of aging. The Kintari YR product line will include a day and night cream. Additional products will be added to enhance this product line as the company grows and expands.

Want to read more?

Log in or subscribe to continue reading this article.

Login to post comments

The Best in the Biz

Anna Babinksa